002399 海普瑞
已收盘 03-10 15:00:00
资讯
新帖
简况
海普瑞遭洪泽君增持121.8万股 每股作价约5.51港元
新浪港股 · 02-04
海普瑞遭洪泽君增持121.8万股 每股作价约5.51港元
股东洪泽君增持海普瑞(09989)481.55万股 每股作价约5.49港元
智通财经网 · 02-02
股东洪泽君增持海普瑞(09989)481.55万股 每股作价约5.49港元
股市必读：海普瑞（002399）预计2025年全年每股收益盈利:0.1936元至0.2569元
证券之星 · 02-02
股市必读：海普瑞（002399）预计2025年全年每股收益盈利:0.1936元至0.2569元
海普瑞（002399）披露2025年度业绩预告，1月30日股价下跌0.72%
证券之星 · 01-30
海普瑞（002399）披露2025年度业绩预告，1月30日股价下跌0.72%
高基数下的正常回归，海普瑞归母净利润预减，扣非预增，主营业务有韧性
深圳商报·读创 · 01-30
高基数下的正常回归，海普瑞归母净利润预减，扣非预增，主营业务有韧性
海普瑞(09989)发盈警，预期年度归母净利润2.84亿元-3.77亿元 同比下降41.71%-56.09%
智通财经 · 01-30
海普瑞(09989)发盈警，预期年度归母净利润2.84亿元-3.77亿元 同比下降41.71%-56.09%
海普瑞全球肝素制剂业务拓展成效显著 全年业绩预期向好
美股速递 · 01-30
海普瑞全球肝素制剂业务拓展成效显著 全年业绩预期向好
海普瑞：公司始终以稳健经营，提升核心竞争力为根本，持续夯实内在价值
证券日报 · 01-19
海普瑞：公司始终以稳健经营，提升核心竞争力为根本，持续夯实内在价值
股市必读：海普瑞（002399）1月13日董秘有最新回复
证券之星 · 01-14
股市必读：海普瑞（002399）1月13日董秘有最新回复
海普瑞：公司将继续加强与资本市场投资者的沟通
证券日报 · 01-13
海普瑞：公司将继续加强与资本市场投资者的沟通
海普瑞选举张平为职工代表董事
财中社 · 2025-12-16
海普瑞选举张平为职工代表董事
较A股折价60%，肝素即将走出下行周期海普瑞(09989)现抄底信号？
智通财经 · 2025-12-06
较A股折价60%，肝素即将走出下行周期海普瑞(09989)现抄底信号？
海普瑞（002399）披露召开2025年第一次临时股东会通知，11月24日股价上涨1.21%
证券之星 · 2025-11-24
海普瑞（002399）披露召开2025年第一次临时股东会通知，11月24日股价上涨1.21%
海普瑞：关于独立董事任期届满离任暨补选独立董事的公告
证券日报 · 2025-11-24
海普瑞：关于独立董事任期届满离任暨补选独立董事的公告
海普瑞(09989)：建议选举浦洪为独立非执行董事
智通财经 · 2025-11-24
海普瑞(09989)：建议选举浦洪为独立非执行董事
股市必读：海普瑞（002399）11月18日董秘有最新回复
证券之星 · 2025-11-20
股市必读：海普瑞（002399）11月18日董秘有最新回复
海普瑞（002399）2025年三季报简析：增收不增利
证券之星 · 2025-11-01
海普瑞（002399）2025年三季报简析：增收不增利
图解海普瑞三季报：第三季度单季净利润同比增长13.14%
证券之星 · 2025-10-30
图解海普瑞三季报：第三季度单季净利润同比增长13.14%
海普瑞：前三季度净利润约5.53亿元
每日经济新闻 · 2025-10-30
海普瑞：前三季度净利润约5.53亿元
海普瑞：公司将持续加强市值管理工作争取为股东带来更好回报
证券之星 · 2025-03-05
海普瑞：公司将持续加强市值管理工作争取为股东带来更好回报
暂无数据
公司概况
公司名称：
深圳市海普瑞药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-06
主营业务：
深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。
发行价格：
148.00
{"stockData":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":11.43,"timestamp":1773126198000,"preClose":11.35,"halted":0,"volume":2983780,"delay":0,"changeRate":0.007,"floatShares":1247000000,"shares":1467000000,"eps":0.2864,"marketStatus":"已收盘","change":0.08,"latestTime":"03-10 15:00:00","open":11.41,"high":11.53,"low":11.33,"amount":34008000,"amplitude":0.0176,"askPrice":11.43,"askSize":691,"bidPrice":11.42,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.2864,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773192600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.35,"symbolType":"stock","openAndCloseTimeList":[[1773106200000,1773113400000],[1773118800000,1773126000000]],"highLimit":12.49,"lowLimit":10.22,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1467296204,"isCdr":false,"pbRate":1.35,"roa":"--","peRate":39.909218,"roe":"4.51%","epsLYR":0.4408,"committee":-0.061981,"marketValue":16771000000,"turnoverRate":0.0024,"status":0,"hkstockBrief":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":5.21,"timestamp":1773130127607,"preClose":5.24,"halted":0,"volume":203500,"delay":0,"premium":"-59.99"},"floatMarketCap":14256000000},"requestUrl":"/m/hq/s/002399/tweets","defaultTab":"tweets","newsList":[{"id":"2608812943","title":"海普瑞遭洪泽君增持121.8万股 每股作价约5.51港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608812943","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608812943?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:04","pubTimestamp":1770163440,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，2月2日，洪泽君增持海普瑞（09989）121.8万股，每股作价5.509港元，总金额约为671万港元。增持后最新持股数目为2246.95万股，最新持股比例为10.20%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-02-04/doc-inhkrayr9887953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09989","BK0070","BK0188","002399","BK0239","BK1191"],"gpt_icon":0},{"id":"2608863744","title":"股东洪泽君增持海普瑞(09989)481.55万股 每股作价约5.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608863744","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608863744?lang=zh_cn&edition=full","pubTime":"2026-02-02 19:06","pubTimestamp":1770030393,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月29日，股东洪泽君增持海普瑞(09989)481.55万股，平均每股作价为5.485港元，总金额约为2641.3万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260202/20260202190651_57581.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260202/20260202190651_57581.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002399","BK0239","09989","BK0070","BK1191","BK0188"],"gpt_icon":0},{"id":"2608188136","title":"股市必读：海普瑞（002399）预计2025年全年每股收益盈利:0.1936元至0.2569元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608188136","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608188136?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:14","pubTimestamp":1769976853,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，海普瑞报收于12.37元，下跌0.72%，换手率0.4%，成交量5.04万手，成交额6235.98万元。来自：海普瑞预计2025年全年扣非后净利润盈利3.62亿元至4.6亿元，同比增长42.78%至81.43%。海普瑞发布业绩预告，预计2025年全年归属净利润盈利2.84亿元至3.77亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","09989","BK0070","BK1191","002399","BK0239"],"gpt_icon":0},{"id":"2607042932","title":"海普瑞（002399）披露2025年度业绩预告，1月30日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607042932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607042932?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:19","pubTimestamp":1769786351,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，海普瑞报收于12.37元，较前一交易日下跌0.72%，最新总市值为181.5亿元。该股当日开盘12.4元，最高12.52元，最低12.24元，成交额达6235.98万元，换手率为0.4%。近日，深圳市海普瑞药业集团股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为28,400万元至37,700万元，同比下降56.09%至41.71%，主要因上年同期存在超过3.5亿元的一次性投资收益导致基数较高。本次业绩预告数据未经会计师事务所审计，最终数据以2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK1191","BK0070","BK0188","09989","BK0239"],"gpt_icon":0},{"id":"2607046318","title":"高基数下的正常回归，海普瑞归母净利润预减，扣非预增，主营业务有韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=2607046318","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607046318?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:32","pubTimestamp":1769779932,"startTime":"0","endTime":"0","summary":"1月30日晚间，海普瑞（002399）发布年度业绩预告，预计2025年全年归母净利润为28400万元~37700万元，同比预减41.71%~56.09%；预计2025年全年扣非净利润为36200万元~46000万元，同比预增42.78%~81.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601303637326839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002399","09989"],"gpt_icon":0},{"id":"2607013138","title":"海普瑞(09989)发盈警，预期年度归母净利润2.84亿元-3.77亿元 同比下降41.71%-56.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607013138","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607013138?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:24","pubTimestamp":1769765086,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞 发布公告，该公司预计截至2025年12月31日止年度归属于上市公司股东的净利润人民币2.84亿元-人民币3.77亿元，同比下降41.71%-56.09%。报告期内，公司归属于上市公司股东的净利润同比有所下降，主要是去年同期存在超过人民币3.5亿元的一次性投资收益，从而形成了较高的基数。此外，报告期内本公司旗下联营公司因研发进展未达预期，预计将对本集团净利润造成一定影响，具体影响以会计师事务所最终确认为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002399","09989"],"gpt_icon":0},{"id":"1191734441","title":"海普瑞全球肝素制剂业务拓展成效显著 全年业绩预期向好","url":"https://stock-news.laohu8.com/highlight/detail?id=1191734441","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191734441?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:24","pubTimestamp":1769765042,"startTime":"0","endTime":"0","summary":"受益于全球肝素制剂业务扩张取得重大进展，海普瑞全年业绩表现值得期待。公司在国际化战略推进下，制剂板块增长动能持续释放，为整体盈利水平提供有力支撑。随着产能布局优化与市场渠道深化，其肝素产业链竞争力进一步凸显，未来业绩弹性有望增强。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0070","BK0188","002399","BK0239"],"gpt_icon":0},{"id":"2604136825","title":"海普瑞：公司始终以稳健经营，提升核心竞争力为根本，持续夯实内在价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2604136825","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604136825?lang=zh_cn&edition=full","pubTime":"2026-01-19 21:09","pubTimestamp":1768828140,"startTime":"0","endTime":"0","summary":"证券日报网讯1月19日，海普瑞在互动平台回答投资者提问时表示，公司始终以稳健经营，提升核心竞争力为根本，持续夯实内在价值，并通过优化公司治理、加强信息披露、投资者关系管理、提高现金分红等方式不断完善市值管理工作，努力让公司价值获得更合理的市场体现，争取为投资者带来更好的回报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601193623547062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","002399","BK1191","BK0070","BK0239","09989"],"gpt_icon":0},{"id":"2603363743","title":"股市必读：海普瑞（002399）1月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603363743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603363743?lang=zh_cn&edition=full","pubTime":"2026-01-14 03:57","pubTimestamp":1768334229,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，海普瑞报收于12.43元，上涨0.73%，换手率0.5%，成交量6.26万手，成交额7838.59万元。董秘： 您好，公司2025年度具体经营业绩敬请关注公司2025年年度报告。股价受多种因素的影响，公司将继续加强与资本市场投资者的沟通，努力让公司内在价值更好地反映在资本市场的市值表现上，争取为投资者带来更好的回报。当日关注点来自交易信息汇总：1月13日主力资金净流入118.63万元，显示主力对海普瑞短期走势持积极态度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400003046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK0239","BK1191","BK0188","09989","BK0070"],"gpt_icon":0},{"id":"2603470681","title":"海普瑞：公司将继续加强与资本市场投资者的沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2603470681","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603470681?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:40","pubTimestamp":1768308041,"startTime":"0","endTime":"0","summary":"证券日报网讯1月13日，海普瑞在互动平台回答投资者提问时表示，公司2025年度具体经营业绩敬请关注公司2025年年度报告。股价受多种因素的影响，公司将继续加强与资本市场投资者的沟通，努力让公司内在价值更好地反映在资本市场的市值表现上，争取为投资者带来更好的回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601133617639895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK1191","BK0188","09989","BK0070","002399"],"gpt_icon":0},{"id":"2591398582","title":"海普瑞选举张平为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2591398582","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591398582?lang=zh_cn&edition=full","pubTime":"2025-12-16 18:39","pubTimestamp":1765881570,"startTime":"0","endTime":"0","summary":"海普瑞（002399/09989）发布公告，公司于2025年12月16日召开2025年第一次临时股东会，审议通过了关于修订《公司章程》的相关议案。根据修订后的《公司章程》，公司董事会将一个非独立董事席位调整为职工董事席位。张平被选举为公司第六届董事会职工董事，任期至第六届董事会届满之日止。2025年前三季度，海普瑞实现收入41.94亿元，归母净利润5.54亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163593149586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002399","BK1191","BK0070","BK0188","09989","BK0239"],"gpt_icon":0},{"id":"2589276842","title":"较A股折价60%，肝素即将走出下行周期海普瑞(09989)现抄底信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2589276842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589276842?lang=zh_cn&edition=full","pubTime":"2025-12-06 14:18","pubTimestamp":1765001919,"startTime":"0","endTime":"0","summary":"今年10月30日，海普瑞披露了公司2025年第三季度财报。归属于上市公司股东的净利润5.54亿元，同比下降29.04%。这便是导致此轮生猪下行周期以及肝素下行周期的重要原因。2025年1月，出口价格环比大幅上涨27%。而这一预期已在海普瑞A股上有所反应，目前海普瑞A股股价12.04元，较去年低点6.64元已拉升81.63%。相较之下，海普瑞港股股价虽在同样区间内也有大幅上涨，但仍较A股股价折价60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002399","BK1191","BK0239","09989","BK0188","399300","BK0070","159982"],"gpt_icon":0},{"id":"2585498536","title":"海普瑞（002399）披露召开2025年第一次临时股东会通知，11月24日股价上涨1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585498536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585498536?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:28","pubTimestamp":1763994491,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，海普瑞报收于11.71元，较前一交易日上涨1.21%，最新总市值为171.82亿元。近日，深圳市海普瑞药业集团股份有限公司发布公告，宣布将于2025年12月16日召开2025年第一次临时股东会，会议由董事会召集，现场会议地点为深圳市南山区南海大道3031号兰赫美特酒店二楼宴会厅。股权登记日为2025年12月8日。其中，《关于取消监事会暨修订<公司章程>及配套议事规则的议案》需经出席股东会的股东所持表决权的三分之二以上通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK1191","BK0070","09989","BK0188","BK0239"],"gpt_icon":0},{"id":"2585467195","title":"海普瑞：关于独立董事任期届满离任暨补选独立董事的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2585467195","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585467195?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:36","pubTimestamp":1763991416,"startTime":"0","endTime":"0","summary":"证券日报网讯11月24日晚间，海普瑞发布公告称，根据有关规定，独立董事在同一上市公司连续任职时间不得超过六年。公司现任独立董事吕川先生连续任职时间即将届满六年。根据前述规定，届满离任后，吕川先生将不再担任包括公司第六届董事会独立董事及董事会专门委员会相应职务（包括提名委员会主任委员、审计委员会委员及战略委员会委员）在内的任何职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511243573239378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09989","BK0239","002399","BK1191","BK0188","BK0070"],"gpt_icon":0},{"id":"2585465856","title":"海普瑞(09989)：建议选举浦洪为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2585465856","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585465856?lang=zh_cn&edition=full","pubTime":"2025-11-24 18:31","pubTimestamp":1763980279,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，董事会建议选举浦洪为独立非执行董事，惟须待股东于临时股东大会上批准后方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1191","BK0188","09989","BK0070","002399"],"gpt_icon":0},{"id":"2584135924","title":"股市必读：海普瑞（002399）11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584135924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584135924?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:28","pubTimestamp":1763573293,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，海普瑞报收于12.26元，下跌0.73%，换手率0.25%，成交量3.16万手，成交额3885.55万元。董秘最新回复投资者： 您好！请问截至10月31日公司股东人数是多少，谢谢！交易信息汇总资金流向11月18日主力资金净流出551.62万元；游资资金净流出114.52万元；散户资金净流入666.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000000681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002399","BK1191","BK0070","BK0239","09989"],"gpt_icon":0},{"id":"2580417858","title":"海普瑞（002399）2025年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2580417858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580417858?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:41","pubTimestamp":1761950498,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海普瑞发布2025年三季报。根据财报显示，海普瑞增收不增利。截至本报告期末，公司营业总收入41.94亿元，同比上升3.09%，归母净利润5.54亿元，同比下降29.04%。按单季度数据看，第三季度营业总收入13.77亿元，同比上升11.82%，第三季度归母净利润1.32亿元，同比上升13.14%。本次财报公布的各项数据指标表现一般。去年的净利率为11.83%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK1191","BK0239","BK0188","002399","09989"],"gpt_icon":0},{"id":"2579141625","title":"图解海普瑞三季报：第三季度单季净利润同比增长13.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579141625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579141625?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:26","pubTimestamp":1761827177,"startTime":"0","endTime":"0","summary":"证券之星消息，海普瑞2025年三季报显示，前三季度公司主营收入41.94亿元，同比上升3.09%；归母净利润5.54亿元，同比下降29.04%；扣非净利润5.52亿元，同比上升28.69%；其中2025年第三季度，公司单季度主营收入13.77亿元，同比上升11.82%；单季度归母净利润1.32亿元，同比上升13.14%；单季度扣非净利润1.26亿元，同比上升26.54%；负债率27.46%，投资收益2566.79万元，财务费用-1.57亿元，毛利率31.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000041062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","09989"],"gpt_icon":0},{"id":"2579631118","title":"海普瑞：前三季度净利润约5.53亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579631118","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579631118?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:15","pubTimestamp":1761815700,"startTime":"0","endTime":"0","summary":"每经AI快讯，10月30日，海普瑞(09989.HK)在港交所发布公告称，2025年前三季度营收约41.94亿元，同比增3.09%；归属于上市公司股东的净利润约5.54亿元，同比降29.04%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-10-30/doc-infvskcs4177499.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-10-30/doc-infvskcs4177499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09989","002399"],"gpt_icon":0},{"id":"2517193729","title":"海普瑞：公司将持续加强市值管理工作争取为股东带来更好回报","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193729?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:51","pubTimestamp":1741179096,"startTime":"0","endTime":"0","summary":"证券之星消息，海普瑞(002399)03月04日在投资者关系平台上答复投资者关心的问题。投资者提问：工资如何维护投资者的利益？是否看好公司未来前景？能否推行员工持股股计划四期，能否回购公司股份注销？能否推动高管增持股份计划？能否2024年度分红扩股？海普瑞回复：您好，公司始终坚持聚焦核心主业，提升公司内在价值，我们将持续加强市值管理工作，促进公司投资价值合理反映公司质量，争取为股东带来更好的回报。谢谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500038393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","09989","BK0188","BK0239","BK0070","BK1191"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773160975008,"stockEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":-0.0639},{"period":"3month","weight":-0.0435},{"period":"6month","weight":-0.1091},{"period":"1year","weight":0.0366},{"period":"ytd","weight":-0.0305}],"compareEarnings":[{"period":"1week","weight":0.0001},{"period":"1month","weight":0.0142},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.064},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海普瑞药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2010-05-06","address":"广东省深圳市南山区松坪山郎山路21号","registeredCapital":"146729万元","survey":" 深圳市海普瑞药业集团股份有限公司的主营业务是肝素产业链，生物大分子CDMO和创新药物的投资，开发及商业化。公司的主要产品是依诺肝素钠制剂、肝素钠、依诺肝素钠原料药、大分子药物CDMO服务。","listedPrice":148},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,002399,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(002399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(002399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}